Clinical Trials Browser

Phase 1 × Doxorubicin × Thoracic × Clear all

NCT00856037 2023-09-26

Topotecan Hydrochloride and Doxorubicin Hydrochloride in Treating Relapsed or Refractory Small Cell Lung Cancer

Phase 1 Completed

Small Cell Lung Carcinoma

NCT00004930 2013-06-19

Inhaled Doxorubicin in Treating Patients With Primary Lung Cancer or Lung Metastases

Phase 1 Completed

Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis, Small Cell Lung Carcinoma

NCT00020124 2012-03-15

Inhaled Doxorubicin in Treating Patients With Advanced Solid Tumors Affecting the Lungs

Phase 1 Completed

Other solid neoplasmThoracic

Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis, Small Cell Lung Carcinoma